COVID-19 vaccine

Anglo-Swedish drugmaker AstraZeneca (NASDAQ:AZN) has sold its entire 7.7% equity stake in COVID-19 vaccine producer Moderna Inc. (NASDAQ:MRNA) for over $1 billion. The company sold the entire stake over the course of 2020, cashing in the meteoric rise of the US biotechnology firm’s shares following its success in the production of a COVID-19 vaccine candidate.
0 Comments
Walmart Inc (NYSE:WMT) is spearheading the vaccination drive against the havoc-causing COVID-19. The nation’s largest retailer has expanded the number of locations where the vaccines are available in Georgia, from 10 to 60. Retail Chain Vaccination Drive Similarly, the number of Sam’s Club locations offering the vaccine has increased from two to six, including 14
0 Comments
The European Medicines Agency has approved AstraZeneca Plc (NASDAQ:AZN) and the University of Oxford’s COVID-19 vaccine. The move comes following a row that AstraZeneca might be breaking its commitment to deliver the vaccine to the EU. AstraZeneca Vaccine approved in the EU On Friday, the EMA said that after assessing the vaccines’ effectiveness and safety,
0 Comments
The U.S real estate sector has shrugged off the shocks triggered by the COVID-19 pandemic to cap one of the finest runs amid a challenging macro environment. Contrary to expectations, the pandemic has fueled activities in the sector as health concernstriggered the digitization of the home buying process. Pandemic Triggered Home Buying As remote-working took
0 Comments
AstraZeneca plc. (NASDAQ: AZN) has quashed concerns about the efficacy of its experimental COVID-19 vaccine. In recent weeks, there have been growing concerns about the vaccine’s ability to combat the deadly virus, especially the new strain causing havoc in Europe. The AstraZeneca vaccine had initially shown an average of 70% effectiveness, but that level is
0 Comments
It promises to be a busy week, with tremendous investment opportunities, on a closer look of the big developments slated for the week ahead. The Coronavirus vaccine’s emergency authorization should be the central theme; a week after the U.K approved the distribution of the much-needed vaccine. COVID-19 Vaccine Authorization The U.S Foods and Drugs Administration
0 Comments
President Donald Trump Administration is already planning for the future as drug maker’s inch closer to gaining regulatory approval for coronavirus vaccines. The administration has confirmed that senior citizens in long-term healthcare facilities will get a vaccine free of charge once made available. Clinical trials The announcement comes at a time when most drug-makers working
0 Comments